贝达药业：嵊州创新药产业化基地将逐步承接公司上市药品的生产需求

Core Viewpoint - The company has proactively planned its production capacity to meet the demands of its listed drugs and has also reserved production capacity for some in-development new drugs [1] Group 1 - The company is gradually transferring the production needs of its listed drugs to the Shengzhou Innovative Drug Industrialization Base [1] - The company will release production capacity based on operational needs [1]